Maynard Um
-
-
-
-
-
-
-
Piper Sandler Reiterates Overweight Rating on Amgen (AMGN)
-
-
-
-
-
-
-
AMGEN announces $300 million US manufacturing investment
-
-
-
-
-
-
-
Canaccord Starts Amgen (AMGN) at Hold
-
-
-
-
-
-
-
RBC Capital: 'Amgen (AMGN) Highlights Key Growth Drivers For The Rest Of 2026 And Beyond'
-
-
-
-
-
-
-
Leerink Partners Reiterates Market Perform Rating on Amgen (AMGN), lowers estimates
-
-
-
-
-
-
-
Amgen (AMGN) PT Raised to $347 at Guggenheim
-
-
-
-
-
-
-
Amgen (AMGN) call put ratio 1 call to 1 put into quarter results
-
416,461 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

